Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127 USD | -0.85% | -1.03% | +2.39% |
Apr. 30 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
Apr. 26 | Wall Street: the worst week of 2024 is followed by the best | CF |
Financials (USD)
Sales 2024 * | 4.33B | Sales 2025 * | 5.15B | Capitalization | 50.53B |
---|---|---|---|---|---|
Net income 2024 * | 715M | Net income 2025 * | 897M | EV / Sales 2024 * | 12 x |
Net Debt 2024 * | 1.43B | Net Debt 2025 * | 994M | EV / Sales 2025 * | 10 x |
P/E ratio 2024 * |
72.4
x | P/E ratio 2025 * |
58.9
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.63% |
Latest transcript on DexCom, Inc.
1 day | -0.85% | ||
1 week | -1.03% | ||
Current month | -0.27% | ||
1 month | -9.46% | ||
3 months | +5.46% | ||
6 months | +35.09% | ||
Current year | +2.39% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 0 M€ | +7.69% | - | |
1.04% | 0 M€ | -4.02% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 127 | -0.85% | 1,689,979 |
24-05-09 | 128.1 | +0.57% | 1,464,257 |
24-05-08 | 127.4 | -2.06% | 1,336,571 |
24-05-07 | 130.1 | +0.35% | 1,425,267 |
24-05-06 | 129.6 | +1.00% | 1,858,416 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.39% | 50.96B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 67.92B | |
+9.36% | 44.7B | |
+2.70% | 40.66B | |
+24.51% | 27.6B | |
+3.43% | 26.63B | |
-0.32% | 24.98B | |
+13.67% | 24.84B |
- Stock Market
- Equities
- DXCM Stock